Cardiovascular Health Supplements Market Report 2025

The cardiovascular health supplements market size has grown rapidly in recent years. It will grow from $13.11 billion in 2024 to $14.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and increased awareness of heart health.

The cardiovascular health supplements market size is expected to see rapid growth in the next few years. It will grow to $23.01 billion in 2029 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals. Major trends in the forecast period include increased collaboration, real-world evidence, product launches, preventive interventions, and innovations.

The forecast of 12% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. preventive cardiology practices by inflating prices of omega-3 cardiovascular supplements manufactured in Norway and Iceland, resulting in limited primary prevention options and higher wellness program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of heart-related diseases is expected to drive the growth of the cardiovascular health supplements market. Cardiovascular diseases (CVD) are disorders that affect the heart and blood vessels. The increase in heart-related diseases is largely due to factors such as lack of physical activity, poor diet, smoking, and chronic stress. Cardiovascular health supplements contain ingredients and nutrients that support heart function, particularly for individuals with heart failure or other heart conditions. For example, in September 2024, the Minnesota Department of Health, a US-based state health agency, reported that approximately 30% of adults in Minnesota had high blood pressure in 2023, affecting nearly 1.4 million people. Additionally, in 2022, hypertensive diseases were the primary or contributing cause of death for 14,225 residents, accounting for nearly 28% of all deaths in the state. As a result, the growing prevalence of heart-related diseases is fueling the demand for cardiovascular health supplements.

Key players in the cardiovascular health supplements industry are directing their efforts towards offering novel natural plant-based products containing ingredients such as dispersible phytosterols, aimed at lowering cholesterol levels and gaining a competitive advantage. Dispersible phytosterols denote a form of plant sterols engineered to readily disperse or dissolve in water, aiding in cholesterol reduction within the body and targeting cardiovascular health. For instance, in September 2023, Nutrartis, a Chile-based health solutions provider, introduced Cardiosmile, a supplement crafted with natural plant sterols. Cardiosmile, available in liquid form, features water-dispersible phytosterols that contribute to cholesterol management and daily heart wellness. Its clinical efficacy lies in its ability to diminish cholesterol absorption, thereby supporting systemic heart and metabolic health while assisting in maintaining healthy cholesterol levels.

In September 2023, Sanofi, a France-based pharmaceutical industry leader, acquired Qunol for an undisclosed sum. This acquisition aimed to bolster Sanofi's consumer healthcare (CHC) and vitamin, mineral, and supplements (VMS) segment, one of the most expansive and rapidly growing consumer health sectors in the United States. Qunol, a US-based healthcare enterprise, specializes in offering a variety of cardiovascular health supplements tailored to the needs of the aging population.

Major companies operating in the cardiovascular health supplements market are Pfizer Inc., Johnson & Johnson, Amway Corporation, Herbalife Nutrition Ltd., General Nutrition Centers Inc. (GNC), NOW Health Group Inc., Garden of Life LLC, Thorne Healthtech Inc., Jarrow Formulas Inc., Life Extension, Designs for Health Inc., Gaia Herbs Inc., Schiff Nutrition International, MegaFood LLC, Twinlab Consolidated Holdings Inc., New Chapter Inc., Integrative Therapeutics LLC, Pure Encapsulations LLC, Doctor's Best Inc., Nature's Bounty Co., Solgar Inc., Renew Life Formulas LLC, Nature Made Nutritional Products, Source Naturals Inc.

Asia-Pacific was the largest region in the cardiovascular health supplements market in 2024. The regions covered in the cardiovascular health supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular health supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular health supplements market consists of sales of fiber supplements, garlic supplements, and magnesium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment - many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The cardiovascular health supplements market research report is one of a series of new reports that provides cardiovascular health supplements market statistics, including the cardiovascular health supplements industry global market size, regional shares, competitors with cardiovascular health supplements market share, detailed cardiovascular health supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiovascular health supplements industry. These cardiovascular health supplements market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cardiovascular health supplements are dietary products designed to promote the health and functionality of the heart and blood vessels. They are commonly utilized to support heart health and prevent or manage various cardiovascular conditions.

The primary types of cardiovascular health supplements include natural and synthetic variants. Natural supplements are derived from sources such as plants, animals, and minerals, and typically comprise ingredients such as vitamins and minerals, herbs and botanicals, omega fatty acids, coenzyme Q10 (CoQ10), among others. These supplements are available in various forms such as liquid, tablets, capsules, softgels, and powders, and are distributed through channels including offline and online.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.